Abstract
The lung is a very attractive target for drug delivery. Currently, as direct access for the treatment of lower respiratory diseases. Possibly, in the future, as the route of administration for systemic therapies. Nebulizers are widely used throughout the world in adult and padiatric medical practice. They are used for the management of acute bronchoconstriction both at home and in hospital, but also for long-term home treatment of various lower respiratory diseases, mainly in elderly and in infants. Overall, bronchodilators are the first class of drugs used by nebulization. The efficiency of the nebulizer has to be assured mainly for suspension, such as corticosteroids, and hyperviscous solution, such as antimicrobials, which aerolize with more difficulties with respect to bronchodilators. Unfortunately, knowledge on the optimal use of nebulizers is limited. Guidelines on best nebulizer practice are often lacking. There is a need to establish some guidance for both the drug and nebulizer manufacturers and prescribing physicians for optimization of nebulizer therapy, individuating not only drugs, dosing and administration schedule, but also the effective nebulizer system and the method for its optimal use and maintenance.
Keywords: Aerosol therapy, nebulizer, inhalation therapy, COPD, asthma
Current Respiratory Medicine Reviews
Title: Nebulizer Therapy in Pulmonology: Review of the Literature
Volume: 2 Issue: 2
Author(s): Andrea S. Melani and Letizia S. Bracci
Affiliation:
Keywords: Aerosol therapy, nebulizer, inhalation therapy, COPD, asthma
Abstract: The lung is a very attractive target for drug delivery. Currently, as direct access for the treatment of lower respiratory diseases. Possibly, in the future, as the route of administration for systemic therapies. Nebulizers are widely used throughout the world in adult and padiatric medical practice. They are used for the management of acute bronchoconstriction both at home and in hospital, but also for long-term home treatment of various lower respiratory diseases, mainly in elderly and in infants. Overall, bronchodilators are the first class of drugs used by nebulization. The efficiency of the nebulizer has to be assured mainly for suspension, such as corticosteroids, and hyperviscous solution, such as antimicrobials, which aerolize with more difficulties with respect to bronchodilators. Unfortunately, knowledge on the optimal use of nebulizers is limited. Guidelines on best nebulizer practice are often lacking. There is a need to establish some guidance for both the drug and nebulizer manufacturers and prescribing physicians for optimization of nebulizer therapy, individuating not only drugs, dosing and administration schedule, but also the effective nebulizer system and the method for its optimal use and maintenance.
Export Options
About this article
Cite this article as:
Melani S. Andrea and Bracci S. Letizia, Nebulizer Therapy in Pulmonology: Review of the Literature, Current Respiratory Medicine Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339806776843067
DOI https://dx.doi.org/10.2174/157339806776843067 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetes and the Chronic Care Model: A Review
Current Diabetes Reviews Antioxidants in Peripheral Arterial Disease
Current Drug Targets Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
Current Pharmaceutical Design Stroke Suggests Increased Risk of Dementia
Current Alzheimer Research MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews A Multicenter Prospective Hospital-based Cohort Study on the Efficacy and Safety of Pitavastatin
Current Diabetes Reviews Pindolol Augmentation of Antidepressant Response
Current Drug Targets Risk Factors for Ischemic Heart Disease
Reviews on Recent Clinical Trials Effects of Hypoxia and Ischemia on MicroRNAs in the Brain
Current Medicinal Chemistry Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Current Medicinal Chemistry Use of Chronic Disease Registries to Optimize Cardiovascular Health
Current Vascular Pharmacology Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design Antioxidant Therapy Against Trypanosome Infections: A Review Update
Current Topics in Medicinal Chemistry Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Current Pharmaceutical Biotechnology The Impact of CRISPR/Cas9-Based Genomic Engineering on Biomedical Research and Medicine
Current Molecular Medicine Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research
Recent Patents on Anti-Cancer Drug Discovery Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
Current Cardiology Reviews Potential Role of IL-18 in the Immunopathogenesis of AIDS, HIVAssociated Lipodystrophy and Related Clinical Conditions
Current HIV Research Antihistamines: Past Answers and Present Questions
Current Drug Safety